CO5150189A1 - Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas - Google Patents

Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas

Info

Publication number
CO5150189A1
CO5150189A1 CO00016924A CO00016924A CO5150189A1 CO 5150189 A1 CO5150189 A1 CO 5150189A1 CO 00016924 A CO00016924 A CO 00016924A CO 00016924 A CO00016924 A CO 00016924A CO 5150189 A1 CO5150189 A1 CO 5150189A1
Authority
CO
Colombia
Prior art keywords
methods
effective amount
analgesic compositions
antiepileptic compounds
compound
Prior art date
Application number
CO00016924A
Other languages
English (en)
Inventor
Mark Richard Hurt
Trevor Mundel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of CO5150189A1 publication Critical patent/CO5150189A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una combinación de una cantidad efectiva de al menos un compuesto antiepiléptico con propiedades que alivian el dolor seleccionados entre gabapentina, pregabalina, carbamazepina, lamotrogina, fenitoína, fosfenitoina y análogos de los mismos, y una cantidad efectiva de al menos un compuesto seleccionado del grupo que consiste en antagonistas del receptor de N-metil-D-aspartato (NMDA), seleccionado entre dextrorfán, dextrometorfán, ketamina, ifenprodil, (15,25)-1-(4-hidroxifenil)2-(4-hidroxi-4-fenilpiperidina)-1-propanol, drogas antiinflamatorias no esteroides (NSAID) seleccionadas entre naproxeno, ibuprofeno, naprosin, diclorofenac, ketofreno, tolmetina, sulindac y análogos.<EMI FILE="00016924_1" ID="1" IMF=JPEG >
CO00016924A 1999-03-10 2000-03-08 Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas CO5150189A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12373999P 1999-03-10 1999-03-10

Publications (1)

Publication Number Publication Date
CO5150189A1 true CO5150189A1 (es) 2002-04-29

Family

ID=22410582

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00016924A CO5150189A1 (es) 1999-03-10 2000-03-08 Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas

Country Status (11)

Country Link
US (1) US6451857B1 (es)
EP (1) EP1161263A1 (es)
JP (1) JP2002538221A (es)
AR (1) AR022723A1 (es)
AU (1) AU3216600A (es)
BR (1) BR0008847A (es)
CA (1) CA2359485A1 (es)
CO (1) CO5150189A1 (es)
PE (1) PE20001558A1 (es)
UY (1) UY26052A1 (es)
WO (1) WO2000053225A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (en) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
ATE311867T1 (de) 1997-09-08 2005-12-15 Warner Lambert Co Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen
CA2373953A1 (en) * 1999-07-02 2001-01-11 Warner-Lambert Company A synergistic combination: gabapentin and pregabalin
ZA200108038B (en) * 2000-10-02 2003-04-01 Pfizer Prod Inc Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists.
US8309570B2 (en) 2001-06-07 2012-11-13 Analgesic Neuropharmaceuticals, Llc Treatment of central neuropathic pain
MXPA04002009A (es) 2001-09-03 2004-07-08 Newron Pharm Spa Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico.
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US6730667B2 (en) * 2001-11-26 2004-05-04 William R. Deagle Iontophoresis disc pain blocker
CA2473536A1 (en) * 2002-01-16 2003-07-31 Endo Pharmaceuticals, Inc. Pharmaceutical composition and method for treating disorders of the central nervous system
JP4428053B2 (ja) * 2002-02-05 2010-03-10 味の素株式会社 ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物
RU2286151C2 (ru) * 2002-02-22 2006-10-27 Уорнер-Ламберт Компани Ллс Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2
US7799832B2 (en) 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
FR2862875B1 (fr) * 2003-12-02 2006-04-07 Mathey Acoustique Service Preparation pharmaceutique pour le traitement des acouphenes
WO2005102390A2 (en) * 2004-04-22 2005-11-03 Pfizer Japan, Inc. Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
ES2556937T3 (es) 2005-12-22 2016-01-21 Newron Pharmaceuticals S.P.A. Derivados de 2-feniletilamino como moduladores de los canales de calcio y/o sodio
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
SG174095A1 (en) * 2006-08-23 2011-09-29 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
BRPI0719590A2 (pt) * 2006-11-28 2014-01-21 Valeant Pharmaceuticals Int Análogos de retigabina 1,4 diamino bicíclica como modulares de canal de potássio
MX2009006575A (es) * 2006-12-22 2009-07-02 Recordati Ireland Ltd Terapia de combinacion de trastornos del tracto urinario inferior con ligandos a2d y farmacos anti-inflamatorios no esteroidales (nsaids).
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
AU2009296457A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
CN105330603A (zh) 2008-10-08 2016-02-17 凯飞药业公司 Gaba偶联物及其使用方法
AU2014364647A1 (en) 2013-12-17 2016-06-23 Laboratorios Del Dr. Esteve, S.A. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Sigma receptor ligands combinations
MA39146A1 (fr) * 2013-12-17 2017-11-30 Esteve Labor Dr Combinaisons de gabapentanoïdes et de ligands des récepteurs sigma
CA2951987C (en) 2014-06-16 2017-10-24 Farmaceuticos Rayere, S.A. Pharmaceutical composition that combines an anticonvulsant and a nicotinic acid derivative
MX2015016589A (es) 2015-12-02 2017-06-01 Samuel CHAIT AUERBACH Jaime Composicion oral veterinaria con gabapentina.
US10874626B2 (en) * 2016-04-07 2020-12-29 Nevakar Inc. Formulation for use in a method of treatment of pain
WO2017200700A1 (en) * 2016-05-16 2017-11-23 PixarBio Corporation Methods for treating incisional pain
WO2019067768A2 (en) * 2017-09-28 2019-04-04 Nevakar, Inc. FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN
EP3691748A4 (en) 2017-10-03 2021-07-07 Nevakar, Inc ACETAMINOPHEN-PREGABALIN COMBINATIONS AND METHODS OF TREATMENT OF PAIN

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4694010A (en) 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
AU4078897A (en) * 1996-08-23 1998-03-06 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
ATE311867T1 (de) * 1997-09-08 2005-12-15 Warner Lambert Co Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen

Also Published As

Publication number Publication date
EP1161263A1 (en) 2001-12-12
JP2002538221A (ja) 2002-11-12
PE20001558A1 (es) 2001-01-28
UY26052A1 (es) 2000-08-21
US6451857B1 (en) 2002-09-17
CA2359485A1 (en) 2000-09-14
AR022723A1 (es) 2002-09-04
BR0008847A (pt) 2001-12-26
AU3216600A (en) 2000-09-28
WO2000053225A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
CO5150189A1 (es) Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas
CU23226B7 (es) COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS
US6406716B2 (en) Anticonvulsant containing composition for treating neuropathic pain
WO1998007447B1 (en) Anticonvulsant containing composition for treating neuropathic pain
CO5270017A1 (es) Prevencion de ruptura de placa por inhibidores acat
GEP20053614B (en) Compositions for Oral Administration Containing Opioid Agonist
DK0845989T3 (da) Smertelindrende lægemiddelsammensætning
JP2001515859A5 (es)
CO5271657A1 (es) Derivados de azaindol
CY1110260T1 (el) Στερεες φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν εναν αγωνιστη υποδοχεα s1p και μια αλκοολη σακχαρων
CO5261529A1 (es) Uso de antagonistas selectivos de receptores de tipo 4(ep4) de la prostaglandina pde2 para el tratamiento de la insuficiencia renal aguda y cronica
CO5180581A1 (es) Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
BR9813826A (pt) Potencial de uso abusivo de administração oral de opióide analgésico
Miranda et al. Dexketoprofen-induced antinociception in animal models of acute pain: synergy with morphine and paracetamol
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ATE411050T1 (de) Arzneimittelabgabesystem
BR9001294A (pt) Sistema para substituivelmente receber tabletes intraorais,sistema para substituivelmente reter e proteger um tablete de medicamento de liberacao controlada intra-oral e dispositivo de subtentacao para tabletes intra-orais
ES2086986T3 (es) Dispositivo de alimentacion para avicultura.
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
AR021934A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
BR9810337A (pt) Utilização de um antagonista especìfico dos receptores 5ht2 para a preparação de medicamentos úteis no tratamento da sìndrome de apnéia do sono
DE69532285D1 (de) Zusammensetzungzur verminderung von schmerzen, die ein nicht narkotischen analgetika und ein analgetikabekräftiger enthält
EA200100581A1 (ru) Комбинация анальгетических лекарственных средств